Related Experiment Video
Updated: Apr 5, 2026

09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
13.4K
Treating Pain in Dementia--Are We Good Enough?
Journal of Pain & Palliative Care Pharmacotherapy
|August 26, 2015
Summary
Many nursing home residents experience undiagnosed pain, especially those with dementia who have communication challenges. Careful consideration of drug treatments is essential for effective pain management in this vulnerable population.
Area of Science:
- Gerontology
- Pain Management
- Neurology
Background:
- Up to 80% of nursing home residents may experience pain.
- Undiagnosed and untreated pain is prevalent in this demographic.
- Impaired communication in individuals with moderate to severe dementia complicates pain self-reporting.
Purpose of the Study:
- To highlight the challenges in diagnosing and treating pain in nursing home residents.
- To emphasize the impact of cognitive impairment on pain perception and reporting.
- To advocate for cautious use of pharmacological interventions.
Main Methods:
- Review of existing literature and clinical observations on pain in the elderly.
- Analysis of communication barriers in pain assessment for dementia patients.
- Consideration of evidence-based guidelines for pain management in geriatric care.
Main Results:
- A significant percentage of nursing home residents suffer from untreated pain.
- Communication deficits in dementia patients hinder accurate pain assessment.
- Pharmacological treatments require careful administration due to potential risks.
Conclusions:
- There is a critical need for improved pain assessment and management strategies in nursing homes.
- Non-pharmacological approaches and careful drug selection are crucial.
- Further research into effective pain management for non-communicative elderly patients is warranted.
Related Concept Videos
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Analgesia and Pain Management
3.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.1K
Drug Therapy
411
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
411
Drug Dosing: Geriatric Patients
357
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
357
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Angina V: Nursing Management
522
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
522

